Are Gilead Shares Overreacting To Merck's Idenix Acquisition?
June 09, 2014 at 14:34 PM EDT
Shares of Gilead Sciences (NASDAQ: GILD) have fallen over four percent following Merck's (NYSE: MRK) purchase of Idenix ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.